NLS Pharmaceutics Ltd (NLSP)
0.138
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.1458
+0.01
(+5.65%)
After-Hours: 20:00
NLS Pharmaceutics Shareholders Equity (Quarterly): -4.287M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -4.287M |
| June 30, 2023 | -4.287M |
| December 31, 2022 | 3.281M |
| June 30, 2022 | -4.042M |
| June 30, 2022 | -4.042M |
| December 31, 2021 | 0.5424M |
| June 30, 2021 | 4.249M |
| June 30, 2021 | 4.249M |
| Date | Value |
|---|---|
| December 31, 2020 | -8.984M |
| June 30, 2020 | -7.334M |
| June 30, 2020 | -7.334M |
| December 31, 2019 | -6.171M |
| June 30, 2019 | -4.197M |
| June 30, 2019 | -4.197M |
| December 31, 2018 | -8.814M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-8.984M
Minimum
Dec 2020
4.249M
Maximum
Jun 2021
-3.039M
Average
-4.197M
Median
Jun 2019
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 191.25M |
| CRISPR Therapeutics AG | 1.883B |
| Addex Therapeutics Ltd | 1.364M |
| Molecular Partners AG | 210.05M |
| MoonLake Immunotherapeutics | 495.68M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.270M |
| Total Liabilities (Quarterly) | 6.557M |